Bo Wei
Impact in
-
- Traditional Chinese Medicine Analysis
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
Papers in
-
- Genomics, phytochemicals, and oxidative stress 4
- Bioactive Natural Diterpenoids Research 2
- Metabolomics and Mass Spectrometry Studies 2
-
- Cardiac Ischemia and Reperfusion 6
- Co-authors
- Hui Ji (4 shared papers)Qinghua Hu (2 shared papers)Wenwen Li (2 shared papers)Xia Xu (9 shared papers)Jingjing Ling (3 shared papers)Xinying Wang (4 shared papers)Ji Zhang (5 shared papers)Jing Ji (1 shared paper)
- Journals
- Phytomedicine (3 papers)European Journal of Medicinal Chemistry (3 papers)International Journal of Cardiology (2 papers)Phytotherapy Research (2 papers)Biomedical Chromatography (2 papers)
- Partner nations
- ChinaNew ZealandHong Kong
In The Last Decade
Bo Wei
56 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 112
- Complementary and alternative medicine 147
- Geriatrics and Gerontology 57
- Cancer Research 129
- Pharmacology 70
- Molecular Biology 490
Countries citing papers authored by Bo Wei
This map shows the geographic impact of Bo Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Wei more than expected).
Fields of papers citing papers by Bo Wei
This network shows the impact of papers produced by Bo Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Wei. The network helps show where Bo Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Bo Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 84 | |
| 2 | 2013 | 78 | |
| 3 | 2021 | 75 | |
| 4 | 2015 | 69 | |
| 5 | 2020 | 66 | |
| 6 | 2018 | 64 | |
| 7 | 2021 | 45 | |
| 8 | 2011 | 40 | |
| 9 | 2019 | 40 | |
| 10 | 2020 | 39 | |
| 11 | 2017 | 38 | |
| 12 | 2021 | 35 | |
| 13 | 2021 | 31 | |
| 14 | 2018 | 30 | |
| 15 | 2020 | 29 | |
| 16 | 2022 | 29 | |
| 17 | 2019 | 24 | |
| 18 | 2022 | 20 | |
| 19 | 2023 | 18 | |
| 20 | 2019 | 17 |
About Bo Wei
Bo Wei is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Oncology, Pulmonary and Respiratory Medicine and Geriatrics and Gerontology, having authored 62 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cardiac Ischemia and Reperfusion (6 papers), Sirtuins and Resveratrol in Medicine (5 papers), Autophagy in Disease and Therapy (4 papers), Ferroptosis and cancer prognosis (4 papers), Genomics, phytochemicals, and oxidative stress (4 papers), Bioactive Natural Diterpenoids Research (2 papers), Metabolomics and Mass Spectrometry Studies (2 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Complementary and alternative medicine (147 citations), Geriatrics and Gerontology (57 citations), Cancer Research (129 citations), Pharmacology (70 citations) and Molecular Biology (490 citations). Bo Wei has collaborated with scholars based in China, New Zealand and Hong Kong. Frequent co-authors include Hui Ji, Qinghua Hu, Wenwen Li, Xia Xu, Jingjing Ling, Xinying Wang, Ji Zhang, Jing Ji, Yaxin Sun and Qiao Lin. Their work appears in journals such as Phytomedicine, European Journal of Medicinal Chemistry, International Journal of Cardiology, Phytotherapy Research and Biomedical Chromatography.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.